Information

Information

Symptoms of Dry Eye

The tear film is a very important layer on the eye surface which maintains the smoothness of the surface for good vision and comfort. It is made up of three layers: mucin, water and lipid. A disturbance in the balance of all three components can lead to symptomatic dry eyes.

A common problem, dry eye disease affects more than 20% of the population with symptoms increasing with age. Conditions of a modern lifestyle including extended exposure to glaring digital screens, driving, artificial lights, air pollution and contact lenses make dry eye syndrome a common nuisance. Generally speaking, it is a result of tear film issue, either caused by insufficient tears or excessive evaporation.

Dry eye disease is an unpleasant sensory and emotional experience for patients. Burdened with discomfort and fear, patients often feel miserable, not knowing how to precisely describe what they are feeling, and most end up feeling exasperated because no one understands. Mild conditions can lead to frequent visits to the eye care practitioners whereas moderate to severe cases is often associated with significant pain, limitations in performing daily activities, reduced vitality, poor general health and in some cases, depression.

Do you experience signs and symptoms which may effect one or more commonly both eyes?

Such as:

  • A stinging, burning or scratchy sensation in your eyes
  • Stringy mucus in or around your eyes
  • Sensitivity to light
  • Eye redness
  • A sensation of having something in your eyes
  • Difficulty wearing contact lenses
  • Difficulty with nighttime driving
  • Watery eyes, which is the body’s response to the irritation of dry eyes
  • Blurred vision or eye fatigue

Dry eye disease is an ocular surface disease that occurs when natural tears are unable to provide adequate lubrication for the eyes. Tears are vital to the overall health of the eyes. With each blink, a protective coating of tears is spread like a film over the front of the eyes. However, when there is an inadequacy or imbalance of tears, dry eyes are often the result.

Tear imbalances are most commonly caused by blockages in the meibomian glands in the eyelids. These small glands produce essential oils that form the top layer of the tear film and are the essential protective element that is crucial to long-term eye comfort and health. Blocked meibomian glands can compromise the effectiveness of the tear film, exposing the eye’s surface and increasing the chances of experiencing the many discomforting symptoms of dry eye.

E-Eye IRPL

The Science of IRPL:

It has been proven in several neurological studies that the emission on a nerve of infrared as a train of pulses leads to the creation of a micro gradient of temperature between the inner and the outer layer of the myelin sheath. This micro gradient of temperature triggers the liberation of neurotransmitters. Automatically, the parasympatic nerve is connected to the Meibomian glands by some of its branches. The neurotransmitters released will then be able to interact with the glands, stimulating the secretion and the contraction of the latter. E-Eye does not directly affect the Meibomian glands. Its action is indirect. The “flashed” areas (buborbital and zygomatic region) are the areas where the parasympathetic nerve passes.

E-Eye is a medical device that has been specifically designed for treating dry eye syndrome due to MGD. It generates Intense Regulated Pulsed Light (IRPL) by producing perfectly calibrated and homogeneously sequenced light pulses. The sculpted pulses are delivered under the shape of a train of pulses. The energy, spectrum and time period are precisely set to stimulate the Meibomian glands in order for them to return their normal function. E-Eye is a medical solution to treat and to prevent dry eyes with MGD. See some references below:

How IRPL works

The dry eye treatment with E-Eye only takes a few minutes, sitting in our custom zero-gravity massage chair. The eyes from the patient are covered by protective eyecups. Hydrogel (ultrasound gel) is applied to the lower eyelid. A series of light pulses is performed around the lower eye which are gentle and non-invasive. The series is repeated in the same way for both eyes. The aim of the treatment is to restore the normal activity of the Meibomian gland. The effect of first two treatments lasts a few days up to 2 to 3 weeks. The long-lasting effect is expected for minimum 6 months up to 3 years. The E-Eye protocol comprises three to five sessions. It is recommended to repeat one application once symptoms are coming back – generally a top up helps keeps the patient asymptomatic every 6-9 months.

Result of Treatment

As a result, the dry lipid layer receives a natural boost of lipids, which reduces the evaporation of tear fluid and prevents the eye from drying out. In addition, the quality of the glandular secretions is improved, and the tear film‘s lipid layer is stabilized. This significantly improves tear break up time and decreased symptomology of the dry eye secondary to MGD.

BlephEx Treatment

Are you tired of dealing with the discomfort and irritation caused by blepharitis? Mark Hinds Optometrists is proud to offer BlephEx, an effective and safe treatment for blepharitis, now available at our practice in Teneriffe.

Blepharitis, a common condition characterized by inflammation of the eyelids, can lead to symptoms such as redness, itching, and a gritty sensation in the eyes. If left untreated, it can even contribute to more serious eye problems. At Mark Hinds Optometrists, we understand the impact that blepharitis can have on your daily life, which is why we are committed to providing effective solutions to help you achieve clearer and more comfortable vision.

The incidence of blepharitis in the general population can vary depending on the demographics studied and the diagnostic criteria used. However, blepharitis is considered to be a relatively common condition affecting a significant portion of the population worldwide.

Studies have suggested that the prevalence of blepharitis ranges from around 20% to 50% in various populations. It tends to be more prevalent in older individuals, with increasing age being a significant risk factor. Other factors such as gender, ethnicity, and environmental factors may also influence the incidence of blepharitis.

Additionally, certain medical conditions such as rosacea and seborrheic dermatitis are often associated with a higher incidence of blepharitis. Individuals with conditions like dry eye syndrome or meibomian gland dysfunction also have an increased risk of developing blepharitis.

Overall, while exact figures may vary, blepharitis is considered to be a common condition affecting a substantial portion of the general population, highlighting the importance of effective management and treatment options. Regular eye examinations and proper eyelid hygiene are essential for preventing and managing blepharitis to ensure optimal eye health and comfort.

With BlephEx, we offer a comprehensive and non-invasive approach to managing blepharitis. This advanced treatment utilizes state-of-the-art technology to gently and precisely remove debris, bacteria, and biofilm buildup along the eyelid margin. By thoroughly cleansing the eyelids, BlephEx helps to alleviate inflammation, reduce symptoms, and promote overall eye health. This procedure can be performed in conjunction with IRPL treatment.

What sets BlephEx apart is its precision and effectiveness. Unlike traditional methods that may only provide temporary relief, BlephEx offers long-lasting results with regular treatments. Our experienced optometrists and dry eye practitioners will customize the treatment to suit your individual needs, ensuring optimal outcomes and enhanced comfort.

At Mark Hinds Optometrists, your eye health and satisfaction are our top priorities. That’s why we strive to stay at the forefront of technology and innovation in optometry. With BlephEx, we are proud to offer our patients a cutting-edge solution for managing blepharitis and maintaining healthy eyes for years to come.

Say goodbye to blepharitis and hello to brighter days ahead. Contact us now to learn more about BlephEx and our comprehensive range of eye care services.

References:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298157/

https://pubmed.ncbi.nlm.nih.gov/34353073/

https://pubmed.ncbi.nlm.nih.gov/33121905/

https://bmcophthalmol.biomedcentral.com/articles/10.1186/s12886-022-02531-7

https://pubmed.ncbi.nlm.nih.gov/28496300/

Our Teams Published Work

https://azuraophthalmics.com/wp-content/uploads/2023/04/FIN_ARVO2023_-Phase-2-RESPONDER-STATUS-AO-OPTH-23-004_v728.pdf

https://www.sciencedirect.com/science/article/abs/pii/S1542012423000885?CMX_ID=&SIS_ID=&dgcid=STMJ_AUTH_SERV_PUBLISHED&utm_acid=279354036&utm_campaign=STMJ_AUTH_SERV_PUBLISHED&utm_in=DM394089&utm_medium=email&utm_source=AC_

Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial

  • Stephanie L. Watson, Lydon W. Jones, Fiona Stapleton, Mark Hinds, Alison Ng, Jacqueline Tan, Yair Alster, Charles Bosworth, Omer Rafaeli, Venita DePuy : The CELESTIAL STUDY Group

The Ocular Surface (Volume 29, July 2023, Pages 537-546)